Clinical trial
A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular…
NCT00444782 · Pharmexa A/S, Industry · Completed
Key facts
| NCT number | NCT00444782 |
|---|---|
| Title | A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. |
| Official title | "Heptovax" - A Phase II, Open-Label Trial Evaluating the Safety and Efficacy of GV1001 in Advanced Hepatocellular Carcinoma. |
| Lead sponsor | Pharmexa A/S, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Hepatocellular |
| Intervention type | Biological |
| Interventions | GV1001 |
| Enrollment | 41 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 8, 2007 |
| Last update posted | Dec 18, 2008 |
| Countries | France, Germany, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: